Femasys (FEMY) Convertible Debt (2023 - 2025)

Femasys (FEMY) reported Convertible Debt of $3.2 million for Q4 2025, down 37.28% quarter-over-quarter from $5.1 million in Q3 2024.

Femasys (FEMY) Convertible Debt (2023 - 2025) Analysis & Trends

Femasys has reported Convertible Debt for 3 years, with the latest figure at $3.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Convertible Debt changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.2 million, changed N/A from the prior year.
  • Convertible Debt for Q4 2025 stood at $3.2 million, down from $5.1 million in the prior quarter.
  • The five-year high for Convertible Debt was $5.1 million in Q3 2024, with the low at $3.2 million in Q4 2025.
  • Historically, Convertible Debt has averaged $4.3 million across 3 years, with a median of $4.5 million in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Femasys 254.59 Mn 249.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.18 Mn
Sep 30, 2024 5.07 Mn
Jun 30, 2024 4.76 Mn
Mar 31, 2024 4.47 Mn
Dec 31, 2023 4.26 Mn